Melatonin & Psilocybin: New Access Rules
- New Zealand is set to make melatonin more accessible while also providing a pathway for patients with treatment-resistant depression to access psilocybin, also known as magic mushrooms.
- While melatonin will soon be available over the counter, psilocybin will remain an unapproved medicine.
- Associate Health Minister david Seymour announced the decisions Wednesday afternoon.
New Zealand is poised to reshape access to melatonin and psilocybin. The government will ease restrictions, allowing over-the-counter availability for primarykeyword, melatonin. Concurrently, it will provide access to the secondarykeyword, psilocybin, via prescription for those facing treatment-resistant depression. This marks a meaningful shift, with health officials announcing the changes on Wednesday. Associate Health Minister David Seymour emphasizes the government’s patient-first approach,aiming to align with global practices. melatonin’s increased accessibility and the allowance of psilocybin prescriptions under expert psychiatric supervision will soon become reality, though implementation dates remain pending. For more on these developments plus other news, tap News Directory 3.Expect further announcements in the coming weeks regarding timelines and health professional guidelines. Discover what’s next…
New Zealand to Ease Access to Melatonin, Psilocybin
New Zealand is set to make melatonin more accessible while also providing a pathway for patients with treatment-resistant depression to access psilocybin, also known as magic mushrooms. The government’s announcement signals a shift in the country’s approach to these substances.
While melatonin will soon be available over the counter, psilocybin will remain an unapproved medicine. However, it can be prescribed under the guidance of a highly experienced psychiatrist, according to officials.
Associate Health Minister david Seymour announced the decisions Wednesday afternoon. No firm date has been established for when these changes will be implemented.
Seymour stated, “Kiwis shouldn’t be left counting sheep or desperate for options when other countries are already using these medicines. The government is committed to putting patients first.”
“In time, adults will be able to buy melatonin directly from a pharmacy with no prescription needed. This is a commonsense decision that will make melatonin more accessible in New Zealand than in many other countries and encourage suppliers bring more products to our shelves,” Seymour said.
Seymour added that the psilocybin change represents a meaningful advancement for individuals battling depression who have weary other treatment avenues.
“If a doctor believes psilocybin can help, they should have the tools to try. The psychiatrist involved has previously prescribed psilocybin in clinical trials and will operate under strict reporting and record-keeping requirements,” Seymour said.
What’s next
The government is expected to announce a timeline for the implementation of these changes in the coming weeks. Health professionals will also receive guidance on prescribing and dispensing the medications.